Glycogen synthase kinase-3β regulates ΔNp63 gene transcription through the β-catenin signaling pathway

Journal of Cellular Biochemistry

Volumn 105, Issue 2, 2008, Pages 447-453

  Chu, Wing Keung ^a   Dai, Pei Min ^a   Li, Hsin Lun ^a   Chen, Jan Kan ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Np63; catenin; GSK 3 ; Promoter

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; 2 (3 CHLORO 4 HYDROXYANILINO) 3 (2 NITROPHENYL)MALEIMIDE; BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM CHLORIDE; PROTEIN P40;

ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME REGULATION; GENE DELETION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

BETA CATENIN; CELL LINE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; LITHIUM CHLORIDE; LYMPHOID ENHANCER-BINDING FACTOR 1; PROMOTER REGIONS, GENETIC; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEINS;

EID: 54849420489     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21839     Document Type: Article

References (32)

1. Bachar-Dahan L, Goltzmann J, Yaniv A, Gazit A. 2006. Engrailed-1 negatively regulates beta-catenin transcriptional activity by destabilizing beta-catenin via a glycogen synthase kinase-3beta-independent pathway. Mol Biol Cell 17:2572-2580.
2. Barbieri CE, Barton CE, Pietenpol JA. 2003. {Delta}Np63{alpha} expression is regulated by the phosphoinositide 3-kinase pathway. J Biol Chem 278:51408-51414.
3. Chu WK, Lee KC, Chow SE, Chen JK. 2006. Dual regulation of the [Delta]Np63 transcriptional activity by [Delta]Np63 in human nasopharyngeal carcinoma cell. Biochem Biophys Res Commun 342:1356-1360.
4. Chu WK, Dai PM, Li HL, Chen JK. 2008. Transcriptional activity of the {Delta}Np63 promoter is regulated by STAT3. J Biol Chem 283:7328-7337.
5. Coghlan MP, Culbert AA, Cross DA, Corcoran SL, Yates JW, Pearce NJ, Rausch OL, Murphy GJ, Carter PS, Roxbee Cox L, Mills D, Brown MJ, Haigh D, Ward RW, Smith DG, Murray KJ, Reith AD, Holder JC. 2000. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem Biol 7:793-803.
6. Crook TNJ, Brooks L, O'Nions J, Allday MJ. 2000. High level expression of deltaN-p63: A mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)? Oncogene 19:3439-3444.
7. Haegel H, Larue L, Ohsugi M, Fedorov L, Herrenknecht K, Kemler R. 1995. Lack of beta-catenin affects mouse development at gastrulation. Development 121:3529-3537.
8. Irarrazabal CE, Burg MB, Ward SG, Ferraris JD. 2006. Phosphatidylinositol 3-kinase mediates activation of ATM by high NaCl and by ionizing radiation: Role in osmoprotective transcriptional regulation. Proc Natl Acad Sci 103:8882-8887.
9. Jho E-h, Zhang T, Domon C, Joo C-K, Freund J-N, Costantini F. 2002. Wnt/{beta}-catenin/Tcf signaling induces the transcription of axin2, a negative regulator of the signaling pathway. Mol Cell Biol 22:1172-1183.
10. Koga F, Kawakami S, Kumagai J, Takizawa T, Ando N, Arai G, Kageyama Y, Kihara K. 2003. Impaired Delta Np63 expression associates with reduced beta-catenin and aggressive phenotypes of urothelial neoplasms. Br J Cancer 88:740-747.
11. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H. 1997. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275:1784-1787.
12. Le Floch N, Rivat C, De Wever O, Bruyneel E, Mareel M, Dale T, Gespach C. 2005. The proinvasive activity of Wnt-2 is mediated through a noncanonical Wnt pathway coupled to GSK-3{beta} and c-Jun/AP-1 signaling. FASEB J 19:144-146.
13. Liu D, Nakano J, Ishikawa S, Yokomise H, Ueno M, Kadota K, Urushihara M, Huang CL. 2007. Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer. Lung Cancer 58:384-391.
14. Massion PP, Taflan PM, Jamshedur Rahman SM, Yildiz P, Shyr Y, Edgerton ME, Westfall MD, Roberts JR, Pietenpol JA, Carbone DP, Gonzalez AL. 2003. Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res 63:7113-7121.
15. Miller JR, Moon RT. 1996. Signal transduction through beta-catenin and specification of cell fate during embryogenesis. Genes Dev 10:2527-2539.
16. Mills AA, Zheng B, Wang X-J, Vogel H, Roop DR, Bradley A. 1999. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398:708-713.
17. Miyata Y, Iwata T, Ohba K, Kanda S, Nishikido M, Kanetake H. 2006. Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: Prognostic implications and clinical significance for invasion and metastasis. Clin Cancer Res 12:6998-7003.
18. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW. 1997. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275:1787-1790.
19. Park B-J, Lee S-J, Kim JI, Lee S-J, Lee C-H, Chang S-G, Park J-H, Chi S-G. 2000. Frequent alteration of p63 expression in human primary bladder carcinomas. Cancer Res 60:3370-3374.
20. Patturajan M, Nomoto S, Sommer M, Fomenkov A, Hibi K, Zangen R, Poliak N, Califano J, Trink B, Ratovitski E, Sidransky D. 2002. [Delta]Np63 induces [beta]-catenin nuclear accumulation and signaling. Cancer Cell 1:369-379.
21. Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, Bondanza S, Ponzin D, McKeon F, De Luca M. 2001. p63 identifies keratinocyte stem cells. Proc Natl Acad Sci 98:3156-3161.
22. Perez-Pinera P, Menendez-Gonzalez M, Valle M, Vega J. 2006. Hypertonicity activates GSK3β in tumor cells. Mol Cell Biochem 291:93-100.
23. Polakis P. 2000. Wnt signaling and cancer. Genes Dev 14:1837-1851.
24. Ratovitski EA, Patturajan M, Hibi K, Trink B, Yamaguchi K, Sidransky D. 2001. p53 associates with and targets Delta Np63 into a protein degradation pathway. Proc Natl Acad Sci 98:1817-1822.
25. Sadot E, Conacci-Sorrell M, Zhurinsky J, Shnizer D, Lando Z, Zharhary D, Kam Z, Ben-Ze'ev A, Geiger B. 2002. Regulation of S33/S37 phosphorylated {beta}-catenin in normal and transformed cells. J Cell Sci 115:2771-2780.
26. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A. 1999. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci 96:5522-5527.
27. Stambolic V. 2002. PTEN: A new twist on [beta]-catenin? Trends Pharmacol Sci 23:104-106.
28. Steinbrecher KA, Wilson W III, Cogswell PC, Baldwin AS. 2005. Glycogen synthase kinase 3{beta} functions to specify gene-specific, NF-{kappa}B- dependent transcription. Mol Cell Biol 25:8444-8455.
29. Teuliere J, Faraldo MM, Deugnier M-A, Shtutman M, Ben-Ze'ev A, Thiery JP, Glukhova MA. 2005. Targeted activation of {beta}-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia. Development 132:267-277.
30. Wang DY, Hsueh YJ, Yang VC, Chen JK. 2003. Propagation and phenotypic preservation of rabbit limbal epithelial cells on amniotic membrane. Invest Ophthalmol Vis Sci 44:4698-4704.
31. Westfall MD, Pietenpol JA. 2004. p63: Molecular complexity in development and cancer. Carcinogenesis 25:857-864.
32. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D, McKeon F. 1998. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activiti. Mol Cell 2:305-316.